About This EventVyome Therapeutics (Nasdaq: HIND), which is building a healthcare platform spanning the US-India innovation corridor, visits the Nasdaq MarketSite in Times Square on August 15th, ...

About This EventFDNY and FDNY Foundation visits the Nasdaq MarketSite in Times Square in honor of the 2025 FDNY Foundation Dinner on September 4.

Super Micro Computer (NASDAQ: SMCI) stock got hit with a wave of selloffs last week in response to the company's latest ...

Palantir's growth continues to be led by U.S. commercial customers adopting its Artificial Intelligence Platform (AIP). The ...

Metis Global Partners sold 156,987 shares of Nvidia. Trade represented 0.5% of Metis Global Partners’ 13F reportable AUM. Post-trade stake: 1,462,935 shares valued at $231.1 million as of June 30, ...

Shares of data analytics powerhouse Palantir Technologies (NASDAQ: PLTR) soared by 141% this year. For two years running, Palantir is the top-performing stock in the S&P 500, and its momentum doesn't ...

About This EventCommerce.com, Inc. (Nasdaq: CMRC), an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver seamless, personalized ...

Find annual and quearterly earnings data for Nike, Inc. Common Stock (NKE) including earnings per share, earnings forecasts at Nasdaq.com.

About This EventJ.P. Morgan Asset Management, visits the Nasdaq MarketSite in Times Square to celebrate the JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF (Nasdaq: HEQQ) and JPMorgan US Tech ...

Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a mini-rally that extended into Friday; the company's share price added nearly 5% ...

At Holdings Channel, we have reviewed the latest batch of the 29 most recent 13F filings for the 06/30/2025 reporting period, and noticed that Eli Lilly (Symbol: LLY) was held by 18 of these funds.

About This EventJourney Medical Corporation (Nasdaq: DERM), is a commercial-stage pharmaceutical company focused on selling and marketing FDA-approved prescription products. The company visits the ...